logo
Select company
Select metric
$ -8.16MConsolidated Income
VS
Market
37
Sector
71
Industry
84
History
59
$ 2.13Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information

Ticker

INM

Company Name

INMED PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INMED PHARMACEUTICALS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

INM - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -8.16M
3/31/2025$ -8.31M
12/31/2024$ -7.91M
9/30/2024$ -6.82M
6/30/2024$ -7.68M
3/31/2024$ -6.08M
12/31/2023$ -6.35M
9/30/2023$ -6.97M
6/30/2023$ -7.95M
3/31/2023$ -15.48M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -10.2M.
  • Over the past 5 years, INMED PHARMACEUTICALS INC's average Cons. Inc. has been $ -10.93M.
  • The median Cons. Inc. for INMED PHARMACEUTICALS INC during this period was $ -8.31M
  • INMED PHARMACEUTICALS INC reached its highest Cons. Inc. over the past 5 years at $ -6.08M.
  • The lowest Cons. Inc. recorded by INMED PHARMACEUTICALS INC in the same timeframe $ -19.14M

INMED PHARMACEUTICALS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
NBY : NOVABAY PHARMACEUTICALS INC $ 3.32MXBIO : XENETIC BIOSCIENCES INC $ -3.08MSPRB : SPRUCE BIOSCIENCES INC $ -48.34MCPHI : CHINA PHARMA HOLDINGS INC $ -3.66MONCO : ONCONETIX INC $ -44.18MSXTP : 60 DEGREES PHARMACEUTICALS INC $ -7.82MBNBX : APPLIED DNA SCIENCES INC $ -13.3MADTX : ADITXT INC $ -25.88MCDT : CONDUIT PHARMACEUTICALS INC $ -19.65MGTBP : GT BIOPHARMA INC $ -9.39M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

INM - Consolidated Income, Last 5 years

$ -19.14M

Minimum

Sep 30, 2022

$ -6.08M

Maximum

Mar 31, 2024

$ -10.93M

Average

$ -8.31M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.21M with a standard deviation of $ 116.71M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 378M
average$ 12.21M
median$ -2.05M
std$ 116.71M